{"id":"midodrine-oral-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Piloerection (goosebumps)"},{"rate":null,"effect":"Pruritus"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Urinary retention"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Midodrine is a prodrug that is metabolized to desglymidodrine, its active metabolite, which selectively stimulates alpha-1 adrenergic receptors on arterioles and venules. This peripheral vasoconstriction increases both systolic and diastolic blood pressure, making it useful for treating conditions characterized by abnormally low blood pressure. The drug does not cross the blood-brain barrier significantly, limiting central nervous system effects.","oneSentence":"Midodrine is an alpha-1 adrenergic agonist that increases blood pressure by constricting blood vessels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:18.779Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Orthostatic hypotension"},{"name":"Symptomatic hypotension"}]},"trialDetails":[{"nctId":"NCT05778838","phase":"PHASE2","title":"Midodrine Effect on the Mortality Rates in Septic Shock Patients","status":"COMPLETED","sponsor":"Noha Mansour","startDate":"2022-11-07","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT06405555","phase":"PHASE2, PHASE3","title":"Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2024-08-01","conditions":"Heart Failure With Reduced Ejection Fraction, Hypotension, LV Dysfunction","enrollment":56},{"nctId":"NCT05803148","phase":"NA","title":"Treatment Strategy of Vasovagal Syncope","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-04-05","conditions":"Syncope, Vasovagal","enrollment":184},{"nctId":"NCT06213935","phase":"NA","title":"Preoperative Oral Midodrine Versus Intraoperative Intravenous Norepinephrine in Preventing Post-spinal Anesthesia Hypotension in Cesarean Section: A Prospective Double-blind Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-02-01","conditions":"Post Spinal Anesthesia Hypotension","enrollment":90},{"nctId":"NCT05287100","phase":"NA","title":"To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-01-01","conditions":"Cirrhosis, Liver","enrollment":35},{"nctId":"NCT05548985","phase":"NA","title":"Midodrine for Prophylaxis Against Post Spinal Hypotension in Elderly Population","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-10-17","conditions":"Hypotension, Spinal Anesthesia, Elderly","enrollment":58},{"nctId":"NCT03431194","phase":"NA","title":"Midodrine is Effective in Management of Intradialytic Hypotension Among Critically-ill Patients With Acute Kidney Injury","status":"COMPLETED","sponsor":"Benha University","startDate":"2016-10-01","conditions":"Acute Kidney Injury","enrollment":80},{"nctId":"NCT05240391","phase":"PHASE3","title":"Midodrine Versus Albumin for Prevention of Paracentesis Induced Circulatory Disturbance","status":"COMPLETED","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2021-02-20","conditions":"Paracentesis-Induced Circulatory Dysfunction","enrollment":50},{"nctId":"NCT04455464","phase":"NA","title":"Effect of Midodrine on HVPG in Advanced Chronic Liver Disease","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-07-11","conditions":"Chronic Liver Disease","enrollment":60},{"nctId":"NCT05060523","phase":"NA","title":"To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-09-19","conditions":"Liver Cirrhosis","enrollment":220},{"nctId":"NCT03129542","phase":"PHASE1","title":"Midodrine Hydrochloride in Early Sepsis","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-08-30","conditions":"Sepsis, Blood Pressure","enrollment":33},{"nctId":"NCT04396548","phase":"NA","title":"Midodrine for Improving Hemodynamics After Spinal Anesthesia","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2020-06-08","conditions":"Hypotension After Spinal Anesthesia","enrollment":70},{"nctId":"NCT04586790","phase":"PHASE2","title":"the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock","status":"UNKNOWN","sponsor":"Ahmed talaat ahmed aly","startDate":"2020-10-15","conditions":"Spinal Shock","enrollment":90},{"nctId":"NCT04474262","phase":"NA","title":"Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-07-15","conditions":"Acute-On-Chronic Liver Failure","enrollment":150},{"nctId":"NCT00108355","phase":"PHASE4","title":"Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2003-12","conditions":"Ascites, Cirrhosis","enrollment":29}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ProAmatine®","Midodrine pill","ProAmatine","Midodrine hydrochloride"],"phase":"marketed","status":"active","brandName":"Midodrine Oral Tablet","genericName":"Midodrine Oral Tablet","companyName":"Institute of Liver and Biliary Sciences, India","companyId":"institute-of-liver-and-biliary-sciences-india","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Midodrine is an alpha-1 adrenergic agonist that increases blood pressure by constricting blood vessels. Used for Orthostatic hypotension, Symptomatic hypotension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":7,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}